143 related articles for article (PubMed ID: 10677241)
1. Treatment of experimental autoimmune encephalomyelitis with adenylate deaminase from Penicillium lanoso-viride.
Nikolajeva V; Eze D; Petrina Z; Muiznieks I
J Autoimmun; 2000 Mar; 14(2):107-13. PubMed ID: 10677241
[TBL] [Abstract][Full Text] [Related]
2. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
Zhitnukhin IuL; Khizhniak MG
Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
[TBL] [Abstract][Full Text] [Related]
3. [Influence of antilymphocyte sera on the development of experimental allergic encephalomyelitis].
Zhitnukhin IuL; Baĭkovskaia MN
Biull Eksp Biol Med; 1976 Jul; 82(7):844-7. PubMed ID: 953349
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of adenylate deaminase (from Penicillium lanoso-viride) against acute infections in mice.
Nikolajeva V; Eze D; Kamradze A; Indulena M; Muiznieks I
Immunopharmacology; 1996 Nov; 35(2):163-9. PubMed ID: 8956980
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cell-mediated inflammation in experimental murine autoimmune encephalomyelitis by radioisotopic labeling.
Linthicum DS; Mackay IR; Carnegie PR
J Immunol; 1979 Oct; 123(4):1799-805. PubMed ID: 479599
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of immunoglobulin treatment in rats with experimental allergic encephalomyelitis].
Mel'nyk VO; Lisianyĭ MI; Biel's'ka LM; Shniakin SA
Fiziol Zh (1994); 2005; 51(6):37-9. PubMed ID: 16485852
[TBL] [Abstract][Full Text] [Related]
9. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
Hughes RA; Leibowitz S
Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
[TBL] [Abstract][Full Text] [Related]
10. [Immunoluminescent study of the sera of guinea pigs with experimental allergic encephalomyelitis].
Zhitnukhin IuL; Zubzhitskiĭ IuN
Biull Eksp Biol Med; 1972 Aug; 73(8):63-5. PubMed ID: 4564367
[No Abstract] [Full Text] [Related]
11. [Modeling of experimental allergic encephalomyelitis in rats and immunomodulation with allogeneic brain cells].
Lisianyĭ MI; Markova OV; Bel's'ka LM
Fiziol Zh (1994); 2001; 47(5):37-40. PubMed ID: 11758466
[TBL] [Abstract][Full Text] [Related]
12. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse.
Brown AM; McFarlin DE
Lab Invest; 1981 Sep; 45(3):278-84. PubMed ID: 6792424
[TBL] [Abstract][Full Text] [Related]
13. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis.
Moore CS; Earl N; Frenette R; Styhler A; Mancini JA; Nicholson DW; Hebb AL; Owens T; Robertson GS
J Pharmacol Exp Ther; 2006 Oct; 319(1):63-72. PubMed ID: 16809479
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis.
Pettersson A; Ciumas C; Chirsky V; Link H; Huang YM; Xiao BG
J Neuroimmunol; 2004 Nov; 156(1-2):58-65. PubMed ID: 15465596
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant role of the lipopolysaccharide from Bordetella pertussis in the induction of experimental allergic encephalomyelitis. Induction of a subacute form in the rabbit and inhibition of this adjuvant effect].
Moulias R; Peetoom F
Pathol Biol; 1968 Oct; 16(19):853-8. PubMed ID: 4302102
[No Abstract] [Full Text] [Related]
17. [Biochemical studies on experimental allergic encephalomyelitis under treatment with antilymphocyte serum].
Diessner H; Schmidt RM
Psychiatr Neurol Med Psychol (Leipz); 1972 Nov; 24(11):640-5. PubMed ID: 4127836
[No Abstract] [Full Text] [Related]
18. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effect of gramicidin S on experimental ocular neuritis and allergic encephalomyelitis.
Matsushima S; Yoshitoshi T; Mahalak SM; Shichi H
Jpn J Ophthalmol; 1990; 34(3):306-13. PubMed ID: 1706788
[TBL] [Abstract][Full Text] [Related]
20. The innate immune response to adjuvants dictates the adaptive immune response to autoantigens.
Staykova MA; Liñares D; Fordham SA; Paridaen JT; Willenborg DO
J Neuropathol Exp Neurol; 2008 Jun; 67(6):543-54. PubMed ID: 18520773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
